Evolution of the Serbian pharmaceutical market alongside socioeconomic transition

References

• Ess SM , Schneeweiss S , Szucs TD . European healthcare policies for controlling drug expenditure. Pharmacoeconomics 2003;21(2):89-103
   PubMed Web of Science ®Google Scholar
• Huys I , Simoens S . European drug shortages: a call for action!. Int J Pharm Pract 2013;21(1):1-2
   PubMedGoogle Scholar
• Karanikolos M , Mladovsky P , Cylus J , et al. Financial crisis, austerity, and health in Europe. Lancet 2013;381(9874):1323-31
   PubMed Web of Science ®Google Scholar
• Mossialos E , Mrazek M , Walley T . Regulating Pharmaceuticals in Europe: Striving for efficiency, equity and quality. Open University Press; London: 2004
   Google Scholar
• Tomanovi S , Ignjatović S . The transition of young people in a transitional society: the case of Serbia. J Youth Stud 2006;9(3):269-85
   Google Scholar
• Mossialos E , Dixon A , Figueras J , Kutzin J . Funding health care: options for Europe. Open University Press; Buckingham – Philadelphia: 2002
   Google Scholar
• Borowitz M , Atun R . The unfinished journey from Semashko to Bismarck: health reform in Central Asia from 1991 to 2006. Centr Asian Surv 2006;25(4):419-40
   Google Scholar
• Jakovljevic MB . Resource allocation strategies in Southeastern European health policy. Eur J Health Econ 2013;14(2):153-9
   PubMed Web of Science ®Google Scholar
• Pantovic B . Recognition as welfare in globalization. Гласник Етнографског института САНУ 2011;LXIX(1):155-64
   Google Scholar
• Goldstein E , Preker AS , Adeyi O , Chellaraj G . Trends in health status, services, and finance: the transition in Central and Eastern Europe (No. 341). World Bank Publications, Washington, D. C;1996
   Google Scholar
• Bandelj N . The global economy as instituted process: the case of Central and Eastern Europe. Am Sociol Rev 2009;74(1):128-49
   Web of Science ®Google Scholar
• Criterion for price fromation fro drug used in human medicine. Available from: www.podaci.net/_gSRB/f/formiranje/formiranje_cena/formiranje_cena.html [Last accessed 5 June 2014]
   Google Scholar
• Medicines and Medicals Devices Agency of Serbia. Preparation of Professional Publications of the Agency. Belgrade, 2014. Available from: www.alims.gov.rs/eng/about-agency/publication/ [Last accessed 5 June 2014]
   Google Scholar
• WHO Collaborating Centre for Drug Statistics Methodology . ATC/DDD Index. Available from: www.whocc.no/atc_ddd_index/?code=L01XC [Last accessed 5 June 2014]
   Google Scholar
• Jakovljevic MB , Djordjevic V , Markovic V , et al. Cross-sectional survey on complementary and alternative medicine awareness among health care professionals and students using CHBQ questionnaire in a Balkan country. Chin J Integr Med 2013;19(9):650-5
   PubMed Web of Science ®Google Scholar
• Cupara С , Djordjevic В , Jakovljevic М . Current legal status and research on complementary and alternative medicine in Serbia. J Altern Med Res 2013;5(3):195-8
   Google Scholar
• National Health Insurance Fund . Available from: www.eng.rfzo.rs/ [Last accessed 5 June 2014]
   Google Scholar
• National Assembly of the Republic of Serbia . Available from: www.parlament.gov.rs/acts/adopted-laws/adopted-laws.628.html [Last accessed 5 June 2014]
   Google Scholar
• Act on content and scope of rights on healthcare financed from obligatory health insurance, including reimbursement rates for year 2014. Official Gazette of Republic of Serbia, No. 3/2014.
   Google Scholar
• Act on content and scope of rights on healthcare financed from obligatory health insurance, including reimbursement rates for year 2009. Official Gazette of Republic of Serbia, Nos. 7/2009 and 82/2009
   Google Scholar
• Arsenijevic J , Pavlova M , Groot W . Out-of-pocket payments for public healthcare services by selected exempted groups in Serbia during the period of post-war healthcare reforms. Int J Health Plann Manage 2013;29(4):373-98
   PubMed Web of Science ®Google Scholar
• Arsenijevic J , Pavlova M , Groot W . Measuring the catastrophic and impoverishing effect of household health care spending in Serbia. Soc Sci Med 2013;78:17-25
   PubMed Web of Science ®Google Scholar
• Radovanovic A , Dagovic A , Jakovljevic M . Economics of cancer related medical care: estimates worldwide and available domestic evidence. Arch Oncol 2011;19(3–4):59-63
   Google Scholar
• Lazic Z , Gajovic O , Tanaskovic I , et al. GOLD stage impact on COPD direct medical costs in elderly. Health Behav & Pub Health 2012;2(3):1-7
   Google Scholar
• Jakovljevic M , Lazic Z , Verhaeghe N , et al. Direct medical costs of COPD diagnosis and treatment, Eastern vs. Western European country: examples of Serbia and Belgium. Farmeconomia Health Econimics and Therapeutic Pathways 2013;14(4):161-8
   Google Scholar
• Biorac N , Jakovljević M , Stefanović D , et al. Assessment of diabetes mellitus type 2 treatment costs in the Republic of Serbia. Vojnosanit Pregl 2009;66(4):271-6
   PubMed Web of Science ®Google Scholar
• Dragan Ilic . Institute of public health of Serbia “Dr Milan Jovanovic Batut”. Health statistical yearbook of republic of Serbia 2012. Beograd, 2012. Available from: www.batut.org.rs/download/publikacije/pub2012.pdf [Last accessed 5 June 2014]
   Google Scholar
• Kovacevic A , Dragojevic-Simic V , Rancic N , et al. End-of-life costs of medical care for advanced stage cancer patients. Vojnosanit Pregl 2015;72(4): In press
   Web of Science ®Google Scholar
• Jakovljevic MB . Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market. Farmeconomia Health Economics and Therapeutic Pathways 2014;15(1):27-32
   Google Scholar
• State and structure of public debt – June 2014. Ministry of finance of Republic of Serbia – Center for public debt. Available from: www.javnidug.gov.rs/upload/Stanje%20i%20struktura/Stanje%20i%20struktura%20-%20SRB%20LATINICA.pdf [Last accessed 7 June 2014]
   Google Scholar
• Quality of care parameters 2008-2012. Clinical Center Kragujevac. Available from: www.kc-kg.rs/kvalitet/kvalitet-rada [Last accessed 7 June 2014]
   Google Scholar
• Delnoij D , Van Merode G , Paulus A , Groenewegen P . Does general practitioner gatekeeping curb health care expenditure? J Health Serv Res Policy 2000;5(1):22-6
   PubMedGoogle Scholar
• Forrest CB . Primary care in the United States: primary care gatekeeping and referrals: effective filter or failed experiment? BMJ 2003;326(7391):692-5
   PubMed Web of Science ®Google Scholar
• Ranković A , Rancić N , Jovanovic M , et al. Impact of imaging diagnostics on the budget–are we spending too much? Vojnosanit Pregl 2013;70(7):709-11
   PubMed Web of Science ®Google Scholar
• Jakovljević M , Ranković A , Rančić N , et al. Radiology Services Costs and Utilization Patterns Estimates in Southeastern Europe – A Retrospective Analysis from Serbia. Value in Health Regional Issues 2013;2(2):218-25
   PubMedGoogle Scholar
• Jakovljevic M . Recent developments among world’s leading generic markets. Medicinski Casopis 2014;48:3
   Google Scholar
• Jakovljevic MB , Nakazono S , Ogura S . Contemporary generic market in Japan - key conditions to successful evolution. Expert Rev Pharmacoecon Outcomes Res 2014;14(2):181-94
   PubMed Web of Science ®Google Scholar
• Yamada T , Chen CC , Yamada T , et al. Pharmaceutical price control policy, pharmaceutical innovation, and health durability. Open Pharmacoeconomics Health Econ J 2010;2:34-46
   Google Scholar
• Nautre B , Georgieva M . Bulgarian hospital reform and the new public management model. A change of role of state or a change of mind? Scr Sci Med 2013;45(4):20-30
   Google Scholar
• Nemec J , Cankar SS , Kostadinova T , et al. Financing Health Care: what Can we Learn from CEE Experience? Administrative Culture 2013;14(2):212-37
   Google Scholar
• Czachowski S , Pawlikowska T . ’These reforms killed me’: doctors’ perceptions of family medicine during the transition from communism to capitalism. Fam Pract 2011;28(4):437-43
   PubMed Web of Science ®Google Scholar
• Gotsadze G , Chikovani I , Goguadze K , et al. Reforming sanitary-epidemiological service in Central and Eastern Europe and the former Soviet Union: an exploratory study. BMC Public Health 2010;10:440
   PubMed Web of Science ®Google Scholar
• Bjegovic V , Vukovic D , Terzic Z , et al. Strategic orientation of public health in transition: an overview of South Eastern Europe. J Public Health Policy 2007;28(1):94-101
   PubMed Web of Science ®Google Scholar
• Ider BE , Adams J , Morton A , et al. Infection control systems in transition: the challenges for post-Soviet Bloc countries. J Hosp Infect 2012;80(4):277-87
   PubMed Web of Science ®Google Scholar